JP2011527984A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527984A5
JP2011527984A5 JP2010549125A JP2010549125A JP2011527984A5 JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5 JP 2010549125 A JP2010549125 A JP 2010549125A JP 2010549125 A JP2010549125 A JP 2010549125A JP 2011527984 A5 JP2011527984 A5 JP 2011527984A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
glucoside
kaempferol
quercetin
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010549125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527984A (ja
Filing date
Publication date
Priority claimed from DE102008012909A external-priority patent/DE102008012909A1/de
Application filed filed Critical
Publication of JP2011527984A publication Critical patent/JP2011527984A/ja
Publication of JP2011527984A5 publication Critical patent/JP2011527984A5/ja
Pending legal-status Critical Current

Links

JP2010549125A 2008-03-06 2009-03-03 虚血性又は炎症性の心疾患及び心臓血管疾患の予防と治療のためのフラボノイド化合物の使用 Pending JP2011527984A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008012909.7 2008-03-06
DE102008012909A DE102008012909A1 (de) 2008-03-06 2008-03-06 Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
PCT/EP2009/052502 WO2009109573A1 (de) 2008-03-06 2009-03-03 Verwendung von flavonoidverbindungen für die propyhylaxe und therapie ischämischer oder entzündlicher herz- und kreislauferkrankungen

Publications (2)

Publication Number Publication Date
JP2011527984A JP2011527984A (ja) 2011-11-10
JP2011527984A5 true JP2011527984A5 (enExample) 2012-04-26

Family

ID=40600026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549125A Pending JP2011527984A (ja) 2008-03-06 2009-03-03 虚血性又は炎症性の心疾患及び心臓血管疾患の予防と治療のためのフラボノイド化合物の使用

Country Status (6)

Country Link
US (2) US20110053874A1 (enExample)
EP (1) EP2268277A1 (enExample)
JP (1) JP2011527984A (enExample)
CA (1) CA2717012A1 (enExample)
DE (1) DE102008012909A1 (enExample)
WO (1) WO2009109573A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2195000B1 (de) * 2007-08-31 2019-09-25 Sanofi-Aventis Deutschland GmbH Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
DE102008012908A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
AU2013330222B2 (en) 2012-10-11 2016-05-12 Armaron Bio Pty Ltd Novel flavonoid compounds and uses thereof
CN113398114B (zh) * 2021-05-28 2022-11-01 浙江大学智能创新药物研究院 3,7,8,4′-四羟基黄酮在制备抗心血管疾病药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1190200C (zh) * 1998-10-29 2005-02-23 默克专利股份有限公司 包括生物黄酮醇类的混合物的组合物
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
ATE322904T1 (de) * 2000-05-25 2006-04-15 Boehringer Ingelheim Int Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
CN1197567C (zh) * 2002-10-21 2005-04-20 中国人民解放军第二军医大学 山奈酚衍生物用于制备防治脑血管疾病药物的用途
JP4989071B2 (ja) 2002-12-31 2012-08-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 赤ブドウ葉抽出物を含むフィルムコート錠

Similar Documents

Publication Publication Date Title
JP2009524695A5 (enExample)
JP2013507408A5 (enExample)
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
PT3150198T (pt) Composições farmacêuticas de ácido 3-(6-(1-(2,2 difluorobenzo[d][1,3]dioxol-5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e sua administração
JP2016053040A5 (enExample)
WO2007135527A3 (en) Benzimidazolyl compounds
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
ME02307B (me) Kristalni (r)-(e)-2-(4-(2-(5-(1-(3,5-diklorpiridin-4-il)etoksi)-1h-indazol- 3-il)vinil)-1h-pirazol-1-il)etanol i njegova upotreba kao inhibitora fgfr
BR112012033715A2 (pt) inibidores de quinase de regulação de sinal de apoptose.
JP2010504301A5 (enExample)
BR112014005134A2 (pt) composição farmacêutica de dissolução rápida
EA201071204A1 (ru) Применение дронедарона для приготовления лекарственного средства для применения в предотвращении госпитализации в кардиологическое отделение или смертности
EA201300159A8 (ru) Использование композиции salvia miltiorrhiza в приготовлении лекарственных препаратов для вторичной профилактики ишемической болезни сердца
WO2011110939A3 (en) Pharmaceutical compositions of substituted benzhydrylpiperazines
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
PH12018500261B1 (en) Azole benzene derivative
HRP20171511T1 (hr) Ivabradin-hidroklorid, oblik iv
WO2011029547A8 (en) Isoxazolidine derivatives
JP2011527984A5 (enExample)
JP2015514797A5 (enExample)
JP2009108025A5 (enExample)
WO2011138265A3 (en) Indole and indazole derivatives as orexin receptor antagonists
WO2010006184A3 (en) Small-molecule inhibitors of hif and angiogenesis
JP2009137951A5 (enExample)
JP2008266291A5 (enExample)